Trade

with

Baxter International Inc
(NYSE: BAX)
AdChoices
69.10
+0.73
+1.07%
After Hours :
69.10
0.00
0.00%

Open

68.98

Previous Close

68.37

Volume (Avg)

2.15M (2.40M)

Day's Range

68.95-69.47

52Wk Range

64.78-77.31

Market Cap.

37.43B

Dividend Rate (Yield )

2.08 (2.92%)

Beta

0.72

Shares Outstanding

541.67M

P/E Ratio (EPS)

19.46 (3.55)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 15.26B

    • Net Income

    • 2.01B

    • Market Cap.

    • 37.43B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 11.90

    • PEG (Price/Earnings Growth) Ratio

    • 2.01

    • Beta

    • 0.72

    • Forward P/E

    • 13.68

    • Price/Sales

    • 2.29

    • Price/Book Value

    • 4.28

    • Price/Cash flow

    • 11.61

      • EBITDA

      • 3.53B

      • Return on Capital %

      • 7.88

      • Return on Equity %

      • 24.41

      • Return on Assets %

      • 7.88

      • Book Value/Share

      • 15.99

      • Shares Outstanding

      • 541.67M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.52 (9/3/2014)

      • Dividend Declaration Date

      • 7/22/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 73.50

        • Credit Rating

        • UR-

        • Analysts

        • 5

        • EPS Estimate

        • 4.36

        • Cashflow Estimate

        • 6.31

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 16.20

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -13.50

          • -15.59

          • Net Income

            Q/Q (last year)

          • -11.90

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 4.32

          • 12.51

          • Net Income

            5-Year Annual Average

          • 0.00

          • 4.16

          • Dividends

            5-Year Annual Average

          • 16.04

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 48.31

            • 52.83

            • Pre-Tax Margin

            • 15.18

            • 15.96

            • Net Profit Margin

            • 11.90

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 50.10

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 18.80

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 14.80

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.87

              • 0.62

              • Current Ratio

              • 1.64

              • 1.97

              • Quick Ratio

              • 0.82

              • 1.16

              • Interest Coverage

              • 13.73

              • 10.47

              • Leverage Ratio

              • 2.96

              • 2.38

              • Book Value/Share

              • 15.99

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 19.12

                • 35.97

                • P/E Ratio 5-Year High

                • 21.77

                • 279.76

                • P/E Ratio 5-Year Low

                • 11.33

                • 148.87

                • Price/Sales Ratio

                • 2.28

                • 3.33

                • Price/Book Value

                • 4.25

                • 4.16

                • Price/Cash Flow Ratio

                • 11.61

                • 17.27

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 24.41

                    (29.60)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • 7.88

                    (10.90)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • 12.41

                    (17.80)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • 31.90k

                  • 25.65k

                  • Inventory Turnover

                  • 2.45

                  • 2.66

                  • Asset Turnover

                  • 0.66

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  2.67B
                  Operating Margin
                  17.48
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  11.61
                  Ownership

                  Institutional Ownership

                  87.08%

                  Top 10 Institutions

                  25.88%

                  Mutual Fund Ownership

                  36.02%

                  Float

                  99.84%

                  5% / Insider Ownership

                  0.46%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    8,831,633

                  • 0.45

                  • 1.63

                  • Vanguard Five Hundred Index Fund

                  •  

                    5,623,462

                  • 0.06

                  • 1.04

                  • Vanguard Institutional Index Fund

                  •  

                    5,487,537

                  • -1.23

                  • 1.01

                  • SPDR® S&P 500 ETF

                  •  

                    5,240,967

                  • -0.67

                  • 0.93

                  • VA CollegeAmerica Income Fund of America

                  •  

                    4,025,000

                  • 50.47

                  • 0.74

                  • VA CollegeAmerica Fundamental Investors

                  •  

                    3,751,755

                  • 0.00

                  • 0.69

                  • Vanguard Windsor™ II Fund

                  •  

                    3,370,600

                  • 0.00

                  • 0.62

                  • BBH Core Select Fund

                  •  

                    2,895,286

                  • 0.00

                  • 0.54

                  • VA CollegeAmerica Growth Fund of America

                  •  

                    2,818,910

                  • 0.00

                  • 0.52

                  • AllianzGI NFJ Dividend Value Fund

                  •  

                    2,462,500

                  • 0.00

                  • 0.45

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Group, Inc.

                  •  

                    27,325,319

                  • +1.82%

                  • 5.04

                  • State Street Corp

                  •  

                    24,490,581

                  • +1.63%

                  • 4.52

                  • BlackRock Fund Advisors

                  •  

                    19,271,703

                  • +2.04%

                  • 3.56

                  • Aberdeen Asset Management PLC

                  •  

                    13,502,069

                  • +2.64%

                  • 2.49

                  • State Farm Mutual Automobile Ins CO

                  •  

                    13,240,194

                  • 0.00%

                  • 2.44

                  • Capital World Investors

                  •  

                    12,622,784

                  • -4.87%

                  • 2.33

                  • Brown Brothers Harriman & Co

                  •  

                    11,876,261

                  • -0.82%

                  • 2.19

                  • Northern Trust Investments, N.A.

                  •  

                    9,915,220

                  • -3.35%

                  • 1.83

                  • Merrill Lynch & Co Inc

                  •  

                    8,037,470

                  • +177.69%

                  • 1.48

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Classic Growth

                  Style

                  Large Core

                  Baxter International Inc is a Delaware corporation incorporated in 1931. The Company is a healthcare company engaged in the development, manufacture and sale of products that save and sustain the lives of people with hemophilia, immu...morene disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company applies a combination of medical devices, pharmaceuticals and biotechnology to create products that advance patient care. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, clinical and medical research laboratories, and by patients at home under physician supervision. The Company operates in two segments namely BioScience and Medical Products. The BioScience business processes recombin...moreant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as bio surgery products; and vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics, as well as products and services related to pharmacy compounding, drug formulation and packaging technologies. The business manufactures solutions and other products for peritoneal dialysis, a home-based therapy, and also distributes products for hemodialysis, which is generally conducted in a hospital or clinic. The Company has its own direct sales force and also makes sales to and through independent distributors, drug wholesalers acting as sales agents and specialty pharmacy or other alternate site providers. The Company faces substantial competition in each of its segments from international and domestic healthcare and pharmaceutical companies of all sizes. The BioScience segment faces competitors from pharmaceutical, biotechnology and other companies. The Medical Products segment faces competition from medical device manufacturers and pharmaceutical companies. The Company’s operations and many of the products manufactured or sold by the Company are subject to extensive regulation by numerous government agencies, both within and outside the United States.lessless

                  Key People

                  Robert L. Parkinson,Jr

                  CEO/Chairman of the Board/Director

                  Mr. Robert J. Hombach

                  CFO/Vice President

                  Jean-Luc Butel

                  President, Divisional/Vice President

                  Jeanne K. Mason

                  Vice President, Divisional

                  Mr. David P. Scharf

                  General Counsel/Vice President/Secretary

                  • Baxter International Inc

                  • One Baxter Parkway

                  • Deerfield, IL 60015

                  • USA.Map

                  • Phone: +1 224 948-2000

                  • Fax: -

                  • baxter.com

                  Incorporated

                  1931

                  Employees

                  61,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: